Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Rough PMIs, Gazprom send European stocks lower

Mon, 05th Sep 2022 12:15

(Alliance News) - Stock markets were being sold off on Monday, after Russia cut off gas supply via a key pipeline and a series of private sector surveys confirmed the damage being done to the European economy.

On Friday, Gazprom said that a gas pipeline to Germany - which was due to reopen at the weekend - would remain shut until a turbine is repaired, cutting off indefinitely an energy supply route to Europe.

"Predictably, wholesale gas prices are soaring, raising the prospect of even higher energy bills for businesses and consumers and sending the pound and the euro to new multi-year lows against the dollar," AJ Bell investment director Russ Mould said.

The euro traded at USD0.9936 midday Monday, down from USD1.0027 late Friday. Sterling was priced at USD1.1510, down from USD1.1575.

The UK will learn Monday who will be its next prime minister, with Liz Truss the favourite to succeed Boris Johnson and take charge as the country battles a spiralling cost-of-living crisis. The result will be announced at 1230 BST, after foreign minister Truss and her rival, former finance minister Rishi Sunak, spent the summer rallying support among the Conservative Party members who cast the final vote.

If she wins, Truss will become the UK's third female prime minister following Theresa May and Margaret Thatcher. The 47-year-old has consistently been ahead of 42-year-old Sunak in polling among the estimated 200,000 Tory members eligible to vote.

The FTSE 100 index was down 51.56 points, or 0.7%, at 7,229.63 midday Monday. The mid-cap FTSE 250 index was down 219.21 points, or 1.2%, at 18,634.01. The AIM All-Share index was down 5.08 points, or 0.6%, at 861.11.

The Cboe UK 100 index was down 0.7% at 722.49. The Cboe 250 was down 1.1% at 15,981.03, and the Cboe Small Companies down 0.3% at 13,682.72.

In mainland Europe, the CAC 40 in Paris was down 1.7%, while the DAX 40 in Frankfurt was 2.4% lower.

"Bullish market drivers are becoming increasingly difficult to find for stock traders, especially in Europe where the energy crisis ramped up again following Gazprom's decision to halt gas deliveries to the EU through one of its key pipelines, as a retaliation measure against the oil purchase price cap set up by leaders of the G7 nations," Pierre Veyret, technical analyst at ActivTrades, said.

"This decision added pressure to an already uncertain macro context and will likely continue to drive [equities] prices down in the short-term."

Brent oil was trading at USD95.51 a barrel, higher than USD94.00 late Friday.

Oil also was being bid up as the OPEC+ countries are expected to agree a modest increase in oil production at a meeting on Monday,

The 13 members of the Organization of the Petroleum Exporting Countries cartel, led by Saudi Arabia, and their 10 partners, led by Russia, are meeting to adjust their quotas for October. Talks were scheduled to start at 1200 BST.

Adding to the downbeat mood was a report showing the eurozone's private sector fell into decline in August, as a drop in demand and cost-of-living concerns led to weakness in business activity.

The S&P Global eurozone services purchasing managers' index swung down to 49.8 points from 51.2 points in July, passing below the neutral mark of 50.0 points to indicate a contraction. The reading for August marked a 17-month low.

As well, the UK services sector's growth slowed in August, as sales took a hit from growing economic uncertainty and reduced client confidence.

The headline seasonally adjusted S&P Global/Chartered Institute of Procurement UK services PMI business activity index fell to 50.9 points in August from 52.6 in July.

Despite being in growth territory, the print came in well short of market expectations, according to FXStreet, of 52.5.

S&P Global noted August's reading was the softest in 18 months.

In London, miners were in the green. Glencore was up 4.1%, Antofagasta 2.0%, Anglo American 1.1% and Rio Tinto was 1.0% higher.

Anchored to the bottom of the FTSE 100 was Dechra Pharmaceuticals, down 9.0%.

The veterinary products firm reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

In the financial year that ended June 30, Dechra reported revenue of GBP681.8 million, up 12% from GBP608.0 million the year before. Pretax profit increased 4.9% to GBP77.6 million, compared to GBP74.0 million in 2021.

With financial year 2022 revenue and profit rising, Dechra lifted its annual payout by 11% to 44.89p from 40.50p a year earlier.

However, Dechra noted that revenue in the second half of the year normalised to historic levels of growth, as the benefit of increased spending on pets seen during the Covid-19 restrictions slowed down.

Among London midcaps, Countryside Partnerships was the best performer, advancing 5.5%.

The housebuilder agreed to be acquired by peer Vistry Group.

The cash-and-shares deal, worth about GBP1.25 billion, values Countryside shares at 249 pence each, a 9.1% premium to its closing price on Friday.

Vistry is offering 0.255 of a share and 60 pence cash for each Countryside share. The merger is expected to close in the first quarter of 2023.

Vistry added it expects the combination to be return-on-capital-employed enhancing from 2024.

Countryside shareholders will own about 37% of enlarged firm. "The combination would create one of the country's leading homebuilders, comprising a top tier housebuilder and a leading partnerships business, with capability across all housing tenures, and delivering much needed affordable housing," Vistry explained.

Vistry expects the combined revenue to increase to over GBP3 billion per year, much higher than its medium term target of around GBP1.6 billion.

Vistry was 0.3% higher.

Heading in the opposite direction, sports car maker Aston Martin shed 9.9%.

It confirmed its plan for the launch of a rights issue to raise GBP575.8 million, supported by a fund controlled by Saudi Arabia's de facto leader.

Aston Martin noted Saudi Arabia's sovereign wealth fund, the Public Investment Fund, Lawrence Stroll's Yew Tree Consortium, and fellow car maker Mercedes-Benz are taking up their full entitlements, amounting to 45% of the total rights issue.

Aston will issue 559 million new shares as part of its rights issue, on the basis of four new shares for every one existing share. The shares will be issued at a price of 103 pence each, reflecting a 79% discount to the company's closing price on Friday last week at 480p.It was trading at 437.46p around midday on Monday.

Looking ahead to the open in New York, the Dow Jones Industrial Average is called up 0.4%, the S&P 500 is called up 0.3%, and the Nasdaq Composite is seen opening 0.1% higher.

Against the yen, the dollar was quoted at JPY140.48, up from JPY140.05.

Gold was quoted at USD1,714.10 an ounce early Monday, up from USD1,713.90 on late Friday.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Sep 2022 09:23

TOP NEWS: Dechra shares down as post-pandemic growth rates slow

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

Read more
5 Sep 2022 08:48

LONDON MARKET OPEN: Countryside and Vistry sign GBP1.3 billion merger

(Alliance News) - Stocks in London were under pressure at the opening bell on Monday, as the mood turned sour on Friday evening after Russia shut off access to a key gas pipeline.

Read more
5 Sep 2022 07:51

LONDON MARKET BRIEFING: Gazprom's move gets week off to bumpy start

(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis.

Read more
5 Sep 2022 07:01

Dechra Pharmaceuticals FY revenues and profits rise

(Sharecast News) - Veterinary pharmaceuticals group Dechra said on Monday that both revenues and profits had risen throughout the twelve months ended 30 June.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 12:16

LONDON MARKET MIDDAY: Pound weakness props up FTSE 100 as oil fades

(Alliance News) - The FTSE 100 remained in the green on Tuesday at midday on account of a weaker pound, but gains ebbed as oil prices retreated from morning highs.

Read more
30 Aug 2022 08:49

TOP NEWS: Dechra Pharmaceuticals buys US manufacturer Med-Pharmex

(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday said it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex Inc for USD260.0 million.

Read more
30 Aug 2022 07:59

LONDON MARKET PRE-OPEN: Bunzl raises full-year margin outlook

(Alliance News) - Stock trading in London is set for a tepid start as UK market participants return from holiday on Tuesday, catching up with Monday's losses in Europe, as investors continue to mull over hawkish remarks from the head of the US central bank.

Read more
30 Aug 2022 07:53

Dechra Pharmaceuticals buys California-based Med-Pharmex for $260m

(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex for $260m (£221.5m).

Read more
21 Jul 2022 17:08

LONDON MARKET CLOSE: Stocks rise; ECB supersizes interest rate hike

(Alliance News) - Stocks in London ended higher on Thursday as investors digested another raft of corporate earnings, while the European Central Bank surprised markets with an aggressive rate hike.

Read more
21 Jul 2022 09:26

Dechra raises £180m in discounted placing for Piedmont deal

(Sharecast News) - Dechra Pharmaceuticals slumped on Thursday after the animal drug maker raised around £180m in a discounted share placing for the acquisition of US-based Piedmont Animal Health.

Read more
21 Jul 2022 09:03

LONDON MARKET OPEN: Large-caps down ahead of ECB; Russian gas resumes

(Alliance News) - Large-cap stocks in Europe struggled in early dealings on Thursday, as traders await a policy decision from the European Central Bank and after gas supplies through the critical Nord Stream pipeline restarted.

Read more
21 Jul 2022 08:47

Dechra Pharmaceuticals raises GBP184 million for acquisition pipeline

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Thursday said it raised GBP184 million in a discounted share placing and subscription for its acquisition pipeline.

Read more
20 Jul 2022 18:34

Dechra to raise GBP180 million to acquire Piedmont Animal Health

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Wednesday said it is planning a fundraise for an acquisition, as it progresses talks for another potential buy.

Read more
14 Jul 2022 08:29

IN BRIEF: Dechra diversifies funding with private placement notes

Dechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of EUR50 million seven year and EUR100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. "The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility." Dechra says.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.